Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025871 | 12602587 | 1 | I | 20160722 | 0 | 20160727 | 20160727 | DIR | 56.00 | YR | M | N | 68.50000 | KG | 20160726 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025871 | 12602587 | 1 | PS | ENALAPRIL | ENALAPRIL | 1 | Oral | Y | D | 0 | 20 | MG | QD | ||||||
| 126025871 | 12602587 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 9 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 11 | C | CALCITRIOL. | CALCITRIOL | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 13 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 15 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 17 | C | CILOSTAZOL. | CILOSTAZOL | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 19 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 21 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 23 | C | INFLIXIMAB | INFLIXIMAB | 1 | 0 | ||||||||||||
| 126025871 | 12602587 | 25 | C | OMEGA-3 FATTY ACIDS-FISH OIL | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126025871 | 12602587 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126025871 | 12602587 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126025871 | 12602587 | Acute kidney injury | |
| 126025871 | 12602587 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126025871 | 12602587 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126025871 | 12602587 | 1 | 20160606 | 20160722 | 0 |